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Abstract
Background: Households play a major role in community spread of influenza and are potential targets for mitigation
strategies.
Methods: We enrolled and followed 328 households with children during the 2010-2011 influenza season; this season was
characterized by circulation of influenza A (H3N2), A (H1N1)pdm09 and type B viruses. Specimens were collected from
subjects with acute respiratory illnesses and tested for influenza in real-time reverse transcriptase polymerase chain reaction
(RT-PCR) assays. Influenza cases were classified as community-acquired or household-acquired, and transmission parameters
estimated.
Results: Influenza was introduced to 78 (24%) households and transmission to exposed household members was
documented in 23 households. Transmission was more likely in younger households (mean age ,22 years) and those not
reporting home humidification, but was not associated with household vaccination coverage. The secondary infection risk
(overall 9.7%) was highest among young children (,9 years) and varied substantially by influenza type/subtype with the
highest risk for influenza A (H3N2). The serial interval (overall 3.2 days) also varied by influenza type and was longest for
influenza B. Duration of symptomatic illness was shorter in children compared with adults, and did not differ by influenza
vaccination status.
Discussion: Prospective study of households with children over a single influenza season identified differences in household
transmission by influenza type/subtype, subject age, and home humidification, suggesting possible targets for interventions
to reduce transmission.
Citation: Petrie JG, Ohmit SE, Cowling BJ, Johnson E, Cross RT, et al. (2013) Influenza Transmission in a Cohort of Households with Children: 2010-2011. PLoS
ONE 8(9): e75339. doi:10.1371/journal.pone.0075339
Editor: Jodie McVernon, Melbourne School of Population Health, Australia
Received May 20, 2013; Accepted August 12, 2013; Published September 25, 2013
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This work was supported by the Centers for Disease Control and Prevention through a cooperative agreement with the University of Michigan (U01
IP000170).
Competing Interests: Dr. Cowling receives consulting fees from Crucell MV. Dr. Monto receives consulting fees from Novartis and GSK. There are no patents,
products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: sohmit@umich.edu
Introduction
Studies of illness in the household have a long history of
providing information on age-specific incidence and characteristics
of respiratory infections [1]. Data on influenza transmission from
household studies carried out decades ago were vital more recently
in developing models to determine national response to an
influenza pandemic [2–4]. These models assessed the role of
vaccines, antivirals and non-pharmaceutical interventions, such as
school closure, in outbreak control. However, concerns have been
expressed about conclusions based on these models because of
known limitations in the data used to define transmission
parameters [5,6].
Households play a major role in community spread of influenza
because of the frequency and intensity of contacts between
household members [1]. During the recent pandemic, a number of
studies of influenza transmission at the household level were
carried out, many in areas outside the United States [7–12]. Most
of these studies identified influenza index cases at contact with the
health care system and then enrolled and followed eligible
household members to observe transmission events. It is not
certain that results from these studies can be generalized to
seasonal influenza transmission. However, these studies have
demonstrated the value and highlighted the need for more
household studies using current laboratory methods to define
illness etiology.
The extent of influenza transmission in households is estimated
based on the secondary infection risk – the proportion of those
exposed to index cases that are subsequently infected. Important
parameters for describing influenza transmission in households
include the serial interval – the time from onset of illness in an
index case to onset in a secondary case, and the duration of
infectiousness [2,3,13]. These parameters can be affected by
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e75339
household environment (e.g. crowding) and the age, health and
vaccination status of index cases and those exposed.
We recruited and followed a cohort of 328 households with
children during the 2010-2011 influenza season in Michigan, and
estimated influenza transmission parameters based on real-time
reverse transcriptase polymerase chain reaction (RT-PCR) con-
firmed outcomes. Previously these data were used to examine
influenza vaccine effectiveness in preventing community and
household-acquired influenza [14]. In contrast to most recent
household studies [7], this study enrolled all participants before the
start of influenza activity in the community, and examined
influenza illnesses, whether medically-attended or not, in a season
with circulation of all three influenza types/subtypes.
Methods
Household Eligibility, Enrollment and Data Collection
The cohort of households was derived from persons who had
selected a primary health care provider from within the University
of Michigan (UM) health system based in Ann Arbor Michigan;
households were targeted for enrollment by direct mail [14].
Eligible households had at least four members, at least two of
whom were children less than age 18 years. Adult household
members provided written informed consent for participation for
themselves and their children, and children age 7 to 17 years
provided their oral assent. Enrollment and all follow-up activities
took place at the research study site at the UM School of Public
Health (UM-SPH). Health system medical records were reviewed
to document the presence of health conditions considered high risk
for complications of influenza [15]; electronic medical records and
a statewide immunization registry were reviewed to document
influenza vaccine receipt for the 2010-2011 season. Households
were surveyed to collect information on household environmental
factors, including crowding, humidification and exposure to
tobacco smoke.
Ethics Statement
The study was reviewed and approved by the institutional
review board at the University of Michigan Medical School.
Influenza Surveillance and Laboratory Testing
Surveillance activities were carried out from October 2010
through April 2011. Households were sent weekly email or
telephone reminders to report all acute respiratory illnesses defined
by two or more of the following symptoms: cough, fever or
feverishness, nasal congestion, chills, headache, body aches or sore
throat. Subjects with symptomatic illness attended an illness visit at
the research study site within 7 days of onset and had a throat
swab (or nasal swab in children ,7 years) collected for influenza
virus identification. Subjects were contacted by telephone 4 to 6
days after the illness visit for collection of follow-up data.
Collected specimens were tested for influenza by means of RT-
PCR using the SuperScript III Platinum One-Step Quantitative
RT-PCR systemH and an ABI 7500 RT-PCR system platform
(Life Technologies). The primers and probes used were developed
by the CDC Influenza Division, and designed for universal
detection of influenza A and B, and subtype identification of
influenza A viruses. Laboratory tests were performed in the
investigators’ respiratory virus laboratory at the UM-SPH.
Statistical Analyses
Households were characterized by size, composition and
environment, and subjects by demographics, health history and
vaccination status. Influenza illnesses were characterized by type/
subtype, reported symptoms, whether medically-attended or
treated with antiviral medications, and by quantification of viral
shedding. Illness duration was calculated as time from illness onset
to reported resolution of illness symptoms; duration of symptom-
atic illness was used as a proxy for duration of infectiousness
[8,16].
Influenza cases were classified as household index cases
(community-acquired influenza) if they were not linked by
transmission from another household member. A secondary
household-acquired illness was defined by transmission link to a
household index case (or co-index cases) if both cases were the
same influenza type/subtype and influenza onset in the secondary
case occurred from 1 to 7 days after illness onset in the index case.
Secondary infection risks - the proportion of those exposed to
index cases that are subsequently infected - were estimated overall
and for each influenza type/subtype, and examined by household
environment, characteristics of index and secondary cases
including age and vaccination status, and with consideration of
the specimen viral loads of index cases.
Households were considered to have influenza introduced if at
least one household member had community-acquired influenza
(index case). Household transmission of influenza was documented
if at least one household member developed influenza following
exposure to a household index case, as defined above. Influenza
illnesses in a household differentiated by type/subtype or
separated by more than 7 days were considered separate
introductions to the household from the community.
The serial interval, the time (days) from onset of illness
symptoms in index cases to onset of symptoms in transmission
linked secondary cases, was calculated with all transmission
considered secondary to the index case [13]. Mean serial intervals
were estimated overall and for each influenza type/subtype;
confidence intervals around estimates were calculated using
bootstrap techniques with 1000 resamples [17].
Categorical data were analyzed by Chi-square test or when
necessary, Fisher exact test; continuous values were analyzed using
Wilcoxon rank sum tests or ANOVA tests when comparing values
across more than two categories. Survival functions were estimated
and compared by log-rank test in analyses examining time to
illness resolution. Statistical analyses were conducted using SAS
version 9.2 (SAS Institute, Cary, NC). A P-value ,.05 was
considered to indicate statistical significance. No correction for
multiple testing was considered.
Results
Characteristics of Households and Participants
By enrollment closure in October 2010, 328 households with
1,441 participants were enrolled. Among enrolled subjects, 58%
were children less than 18 years, 11% had high risk health
conditions and 60% had documentation of influenza vaccine
receipt for the 2010-11 season [14]. Participant characteristics and
distributions of influenza outcomes are presented in Table 1.
Household size ranged from 4 to 9 members (mean 4.4,
SD = 0.7); mean household age was 22 years (SD = 5.9, range 10
to 38 years). In 55% of households more than half of subjects had
documented evidence of influenza vaccine receipt. Most (78%)
households reported home humidification; less than 2% reported
household exposure to tobacco smoke. Household crowding was
estimated based on number of persons per room with values less
than the household median (0.6) indicating less crowded condi-
tions. Household characteristics and distributions of households
with influenza introduced and transmission documented are
presented in Table 2.
Influenza Transmission in Households
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Illness Surveillance and Influenza Outcomes
Influenza circulated locally between early January and early
April 2011; the epidemic curve based on study surveillance is
presented in Figure 1. During this period, 465 (32%) individuals
from 193 (59%) households reported 605 acute respiratory
illnesses and 580 (96%) specimens were collected. All specimens
were tested for influenza viruses by RT-PCR and 130 (22%) were
determined to be positive for influenza, including 59 (45%) type A
(H3N2), 44 (34%) type B, 26 (20%) type A (H1N1)pdm09 and 1
(1%) type B/ type A (H1N1)pdm09 co-infection [14]. Antigenic
testing was not performed on study specimens; however, all viral
isolates assessed in another study conducted in the same
community were considered antigenically similar to the vaccine
strains [18].
Quantification of viral shedding was estimated based on cycle
threshold (Ct) values from RT-PCR testing using previously
established cut points [19]; 36 (28%) influenza positive specimens
had high (Ct ,25), 41 (32%) had medium (Ct 25–30) and 53
(41%) had low (Ct 31–39) viral loads. Ct values were correlated
with time from illness onset to specimen collection with fewer
(mean) days for those with higher viral loads (1.9 high, 2.2
medium, 2.5 low [P = .09]). The mean time from illness onset to
specimen collection was 2.6 days for specimens testing negative for
influenza, and 2.3 days for specimens testing positive for influenza
(P = 0.12). Ct values did not significantly differ by virus type.
Subjects with laboratory-confirmed influenza were significantly
more likely to report symptoms of fever, cough, chills, body aches
(all P,.001) and fatigue (P = .043) than subjects with non-influenza
acute respiratory illnesses, however, median illness duration was
similar (8 vs. 9 days, P = 0.93). Forty-two (32%) influenza cases
were medically-attended based on medical record review and
three cases (2%) were treated with antiviral medications; two of the
three treated cases were children, both had high risk health
conditions. Median illness duration significantly varied by age
category with shorter duration of symptoms among children
compared with adults (7 days vs. .10 days, P = .01) (Figure 2);
illnesses were not yet resolved for 52% of influenza cases at time of
final illness follow-up. Illness duration did not significantly vary by
influenza type/subtype, or based on presence of high risk health
condition or the influenza vaccination status (9 days vaccinated
cases vs. 7 days unvaccinated cases, P = .53) (Figure 2) of case
subjects.
Influenza Risk by Household and Participant
Characteristics
Influenza was identified in 78 (24%) households and 125 (9%)
individuals, including 5 individuals with two separate influenza
infections (all .14 days apart; 3 of 5 had both influenza type A
and type B infections). Younger households (those with mean age
,22 years) and households with young children (age ,9 years)
Table 1. Characteristics of all household members, those with laboratory-confirmed influenzaa, household index casesb, exposed















N (%e) N (%f) N (%e) N (%e) N (%f)
Age category
,9 years 468 (32.5) 70 (15.0)** 50 (58.8) 84 (31.5) 14 (16.7)*
9 – 17 years 371 (25.7) 23 (6.2) 17 (20.0) 55 (20.6) 2 (3.6)
$18 years 602 (41.8) 32 (5.3) 17 (21.2) 128 (47.9) 10 (7.8)
Sex
Female 728 (50.5) 57 (7.8) 39 (45.9) 133 (49.8) 11 (8.3)
Male 713 (49.5) 68 (9.5) 46 (54.1) 134 (50.2) 15 (11.2)
Documented high risk health
condition
Any 162 (11.2) 19 (11.7) 14 (16.5) 26 (9.7) 4 (15.4)
None 1279 (88.8) 106 (8.3) 71 (83.5) 241 (90.3) 22 (9.1)
Documented influenza vaccine
receipt
Yes 866 (60.1) 74 (8.5) 48 (56.5) 152 (56.9) 18 (11.8)
No 575 (39.9) 51 (8.9) 37 (43.5) 115 (43.1) 8 (7.0)
Total 1,441(100) 125 (8.7) 85 267 26
*P-value , 0.05 from Chi-square test for independence of outcome across categories.
**P-value , 0.001 from Chi-square test for independence of outcome across categories.
aIncludes all 125 individuals with laboratory-confirmed influenza (both index and secondary cases).
bIncludes 85 index/co-index cases from the first household introductions of influenza only; 15 index/co-index cases from second household introductions of influenza
were excluded.
cIncludes 267 household members who were exposed to 85 index/co-index cases from the first household introductions of influenza.
dIncludes 26 secondary cases resulting from the first household introductions of influenza; 4 secondary cases resulting from second household introductions of
influenza were excluded.
eThe percent values presented are column percentages that add to 100 for each participant characteristic.
fThe percent values presented are row percentages with the cell immediately to the left as the denominator.
doi:10.1371/journal.pone.0075339.t001
Influenza Transmission in Households
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were more likely to have influenza introduced (Table 2). None of
household size or crowding, household vaccination coverage,
humidification or exposure to tobacco smoke was significantly
associated with likelihood of influenza introduction.
Overall influenza infection risks significantly varied by subject
age category (P,.001) and were highest among children age ,9
years (15.0%) and lowest among adults (5.3%) (Table 1). There
were no significant differences in influenza infection risk by sex,
presence of high risk health condition or documented influenza
vaccine receipt.
Household Transmission of Influenza
There were 91 total introductions of influenza to 78 households
by 100 index or co-index community-acquired cases. Thirteen
households had two introductions each (differentiated by influenza
type/subtype or time); co-index cases (identical illness onset dates)
were identified in eight introduction events – seven with two index
cases and one with three index cases.
Household transmission of influenza was demonstrated in 23
(29%) households as a result of first (n = 20) or second (n = 3)
influenza introductions, with 30 cases of secondary household
acquired influenza identified. Seventeen introductions each
produced one secondary case, five each produced two secondary
cases, and one produced three secondary cases. The likelihood of
household transmission was not associated with household size,
vaccination coverage, crowding or exposure to tobacco smoke, but
was more likely in households with younger mean household age
(,22 years)(P,.05) and households reporting no home humidi-
fication (P = 0.10) (Table 2).
Multiple introductions of influenza to some households com-
plicated examination of the characteristics of index cases and those
exposed, and estimation of secondary infection risks, as some
subjects were both index cases and exposed household members.
As a result only the first household introductions of influenza were
considered here. First introductions to 78 households, committed
by 85 index or co-index cases, exposed 267 household members
Table 2. Household characteristics and the distributions of households with influenza introduceda and transmission
documentedb: the Household Influenza Vaccine Effectiveness (HIVE) study, Ann Arbor Michigan, 2010-2011 influenza season.





N (%c) N (%d) N (%d)
Household size: participants/household
4 members 234 (71.3) 49 (20.9) 16 (32.7)
5 or more members 94 (28.7) 29 (30.9) 7 (24.1)
Household mean age category
10 – 17 years 81 (24.7) 21 (25.9)* 6 (28.6)*
18 – 21 years 91 (27.7) 30 (33.0) 13 (43.3)
22 – 25 years 65 (19.8) 12 (18.5) 0 (0.0)
26 – 38 years 91 (27.7) 15 (16.5) 4 (26.7)
Households with young children (,9 yrs)
Yes 238 (72.6) 65 (27.3)* 20 (30.8)
No 90 (27.4) 13 (14.4) 3 (23.1)
Household vaccination coverage
None, 0% 84 (25.6) 21 (25.0) 6 (28.6)
.none, #50% 65 (19.8) 14 (21.5) 6 (42.9)
.50%, ,100% 64 (19.5) 16 (25.0) 4 (25.0)
100% 115 (35.1) 27 (23.5) 7 (25.9)
Persons per room in home e
$ Median (0.6): more crowded 152 (50.0) 43 (28.3) 11 (25.6)
, Median (0.6): less crowded 152 (50.0) 32 (21.1) 11 (34.4)
Humidification of home e
Yes 238 (78.3) 61 (25.6) 15 (24.6)
No 66 (21.7) 14 (21.2) 7 (50.0)
Exposure to tobacco smoke in home e
Yes 5 (1.6) 1 (20.0) 0 (0.0)
No 299 (98.4) 74 (24.8) 22 (29.7)
Total 328 (100.0) 78 (23.8) 23 (29.5)
*P-value , 0.05 from Chi-square test for independence of outcome across categories.
aAt least one household index case with community-acquired influenza.
bAt least one secondary case of influenza resulting from exposure to a household index case.
cThe percent values presented are column percentages that add to 100 for each household characteristic.
dThe percent values presented are row percentages with the corresponding cell in the All Households column as the denominator.
eData missing for 24 households (3 with introduction of influenza, 1 of which resulted in secondary transmission).
doi:10.1371/journal.pone.0075339.t002
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and resulted in 26 secondary household-acquired cases in 20
households for a secondary infection risk of 9.7% [26/267].
Characteristics of household index cases, exposed household
members and household secondary cases are presented in Table 1.
Household index cases were most likely to be young (,9 years)
children (59%) and equally likely to be older children (20%) or
adults (21%); 17% of index cases had a high risk health condition
and 57% had documented influenza vaccine receipt. The
secondary infection risk among exposed household members
significantly varied (P = .02) by age category of exposed subjects;
risk was highest among young children (16.7%), lowest among
older children (3.6%) and intermediate for adults (7.8%).
Secondary infection risks were higher among exposed household
members with high risk conditions and those with documented
influenza vaccine receipt, but not significantly.
Secondary infection risks by characteristics of household index
cases are presented in Table 3. Secondary risks did not
significantly vary based on the age, health or vaccination status
of household index cases. Household members exposed to index
cases with high or medium specimen viral loads had a significantly
higher secondary infection risk than those exposed to index cases
with low specimen viral loads. Secondary infection risks varied
significantly by influenza type/subtype with the highest secondary
risk for influenza A (H3N2) [15.3%] and the lowest for influenza A
(H1N1)pdm09 [2.9%]; influenza B was intermediate [7.7%].
The serial interval was calculated overall and by influenza type/
subtype, with secondary cases resulting from both first and second
influenza introductions to households considered. The mean serial
interval was 3.2 days overall (Table 4). Serial intervals were similar
for influenza A (H3N2) and A (H1N1)pdm09 (2.5 vs. 2.8 days), but
significantly longer for influenza B (4.9 days, P = .02).
Discussion
Our household study was originally designed and statistically
powered to estimate influenza vaccine effectiveness in preventing
community acquired influenza [14], with a secondary objective of
examining influenza transmission parameters. In contrast to other
studies carried out to describe influenza transmission, we utilized a
cohort design with long term follow-up of households, and
required that households had at least four members including at
least two children. This strategy increased the likelihood of
studying households with influenza introduction and the oppor-
tunities for examining factors, including both subject and
household characteristics, associated with transmission. Influenza
outcomes were laboratory-confirmed and illnesses of any severity
considered.
It has been estimated that approximately one-third of all
influenza transmission occurs within households [1]. The likeli-
hood of infection following exposure in the household is thought to
be far greater than in the community, because of the frequency
and intensity of contacts [20]. For this reason, interventions
targeting household transmission may be particularly effective in
reducing the impact of influenza outbreaks. Because much of the
existing knowledge about household transmission has come from
studies carried out decades ago or during the recent pandemic,
current estimates of household transmission parameters are of
particular value for planning and modeling seasonal influenza
interventions.
Secondary infection risks describe the extent of influenza
transmission in the household setting and estimated values may
vary by study design, influenza type/subtype, the infectiousness of
index cases and the susceptibility of contacts [7]. Our estimated
secondary infection risk (9.7%) falls in the mid-range of estimates
reported from studies with similar designs (4%–17%) [10–12,21–
22]; however, we may have underestimated the actual value.
Studies, such as ours, that test only symptomatic household
members generally report lower estimates than those testing all
household contacts of symptomatic cases [7]; however, our case
definition was designed to facilitate collection of specimens from
even mild illnesses. Further, co-index cases were identified in 8 of
91 household introductions of influenza. This could have resulted
by chance, common exposure, or inaccurate reporting of illness
onset dates. If reported onset dates were inaccurate, some
secondary cases may have been misclassified as co-index cases
resulting in a lower estimate. Finally, asymptomatic or sub-clinical
infections were not considered. Estimates of the proportion of
Figure 1. Number of specimens collected and number of influenza positive cases by week during 15 week period of influenza
circulationa,b: the Household Influenza Vaccine Effectiveness (HIVE) study, Ann Arbor Michigan, 2010–2011 influenza season.
Footnotes: a Week ending January 1, 2011 through week ending April 9, 2011. b 465 (32%) individuals from 193 (59%) households reported 605 acute
respiratory illnesses and 580 (96%) specimens were collected. All specimens were tested for influenza viruses by reverse-transcriptase real-time
polymerase chain reaction assay and 130 (22%) were determined to be positive for influenza, including 59 (45%) type A (H3N2), 44 (34%) type B, 26
(20%) type A (H1N1) pdm09 (pH1N1) and 1 (1%) type B/ type A (pH1N1) co-infection.
doi:10.1371/journal.pone.0075339.g001
Influenza Transmission in Households
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infections that are asymptomatic vary and their contribution to
transmission is unclear [9,16,23].
Consistent with previous reports [8,11–12,21], we found
household index cases were most likely to be young children
(,9 years), and secondary infection risks were highest among
young (,9 years) contacts. This suggests that interventions
designed to interrupt household transmission may be particularly
effective if they intervene on contacts with or between children
(e.g. isolation). We also observed that secondary infection risks
were higher among adult contacts (7.8%) of index cases than
among exposed older children (3.6%) (P = 0.35); in subsequent
study years, we are examining care-giving behaviors as a possible
explanation for this finding. Interestingly, households with
influenza introduced were less likely to experience secondary
transmission if they reported home humidification, but this effect
was not statistically significant. A relationship between humidity
and influenza transmission has been previously reported [24], and
this finding suggests another possible intervention to reduce
household transmission.
Secondary infection risks significantly varied by influenza type/
subtype with the highest risk among those exposed to type A
(H3N2) [15.3%], even though risks of community-acquired
infection (A (H3N2) [2.9%], A (H1N1)pdm09 [1.5%], and B
[2.6%]) were similar for all types/subtypes [14]. Variation in
secondary risk by influenza type/subtype could be due to
differences in levels of immunity among household contacts [7–
8]. Prior to the 2010–2011 season, subjects were likely exposed to
both waves of the 2009 H1N1 pandemic, influenza A (H3N2) had
not been the dominant circulating strain since the 2007–2008
season, and influenza B had circulated at relatively low levels.
Unfortunately, we were unable to judge immune susceptibility to
influenza infection in this season. In subsequent study years, we
are collecting blood specimens from participants at multiple time
points; inclusion of serologic assessments of immunity should allow
calculation of infection risks among subjects with different levels of
susceptibility. Serologic data may also permit estimation of the
number of asymptomatic (or unreported) infections, although
serologic confirmation of infection in the vaccinated is problematic
[25], and the sensitivity of the traditional four-fold rise to
determine infection remains uncertain [26].
Previous estimates of the serial interval for influenza have
ranged from 1 to 4 days, with most estimates falling between 2.5 to
3.5 days [7,13,27]. Our observed household serial interval (overall
3.2 days) was consistent with these prior estimates. We considered
all secondary cases to be transmitted from the index case, with no
tertiary transmission. Failure to consider chains of transmission
can result in overestimation of the serial interval; however, here
the mean serial interval was similar if potential tertiary transmis-
sion was considered (3.1 vs. 3.2 days). Based on a relatively small
number of secondary cases, we found the serial interval for
influenza B (4.9 days) was significantly longer than for influenza A
(H3: 2.5 days, H1: 2.8 days). Serial intervals can be influenced by
contact patterns (number, intensity, and duration), infectivity of
index cases, and susceptibility of contacts. The longer serial
interval for influenza B is consistent with lower infectivity for
influenza B, and the relatively higher vaccine effectiveness against
influenza B estimated for the 2010–2011 season [14,18].
Illnesses were followed with a single follow-up contact 4 to 6
days after the illness visit (which occurred up to 7 days after illness
onset) and at that time, half of the influenza cases noted their
illnesses were not yet resolved. Our estimate of median illness
duration of 8 days is similar to previously reported estimates
ranging from 7 to 11 days [20,25,28]. The relationship between
reported duration of illness symptoms and the duration of
infectiousness is unclear. Viral shedding as measured by RT-
PCR has been shown to correlate with illness symptoms [8,16];
however, the infectious period has also been estimated to be days
shorter than the duration of symptoms [20]. Our findings that
adults had relatively longer reported illness duration will be
investigated further in subsequent study years with more thorough
follow-up to capture resolution of all illnesses. Our finding that
illnesses in which influenza was identified were more likely than
non-influenza respiratory illnesses to be characterized by fever,
cough, chills, body aches and fatigue is similar to previous reports
[29–31].
In our descriptive analysis, household and subject characteristics
associated with transmission parameters were not examined in
multivariable adjusted models. The value of using traditional
multivariable statistical models was limited by small sample size
Figure 2. Days from influenza illness onset to resolution of
symptoms by age and influenza vaccination: the Household
Influenza Vaccine Effectiveness (HIVE) study, Ann Arbor
Michigan, 2010-2011 influenza season. Footnotes: + Censored
observations. * P-value from Log-Rank test.
doi:10.1371/journal.pone.0075339.g002
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and complicated by factors such as influenza introduction by co-
index cases, multiple introductions of influenza to a household
from the community and varying risk status as household
infections occurred. More complex models, including dynamic
systems models [20], are necessary to fully utilize these data to
make inferences about influenza transmission and transmission
parameters.
Our objectives here were to describe transmission in households
with children, and examine factors and parameters that affected
transmission. Enrolled households were highly vaccinated and as
previously reported, we found no evidence of vaccine effectiveness
in preventing household-acquired influenza [14]. Further, our
findings of high household transmission risk for influenza A
(H3N2), despite similar community risks across influenza types/
subtypes, are consistent with the poor vaccine effectiveness
demonstrated against A (H3N2) that season [14,18,32]. These
findings highlight the need for improved vaccines, but also
emphasize the potential value of non-pharmaceutical interventions
in reducing household transmission of influenza.
Table 3. Secondary infection risks by characteristics of household influenza index casesa: the Household Influenza Vaccine
Effectiveness (HIVE) study, Ann Arbor Michigan, 2010-2011 influenza season.
Characteristic of Index Case Number of Household Contacts Exposed Number of Secondary Cases Secondary Infection Risk
Age ,9 years
Yes 154 17 11.0%
No 113 9 8.0%
Male
Yes 146 16 11.0%
No 121 10 8.3%
Documented High Risk
Health Condition
Yes 51 7 13.7%
No 216 19 8.8%
Documented influenza vaccine receipt
Yes 164 19 11.6%
No 103 7 6.8%
RT-PCR Ct # 30b
Yes 144 19 13.2%*
No 123 7 5.7%
Influenza type (subtype)
A (H3N2) 111 17 15.3%**
A (pH1N1)c 68 2 2.9%
Bc 91 7 7.7%
Total 267 26 9.7%
*P-value , 0.05 from Chi-square test for independence of outcome across levels of categorical exposure.
**P-value , 0.001 from Chi-square test for independence of outcome across levels of categorical exposure.
aOnly the first household introductions of influenza are considered here; 15 index/co-index cases, and 4 secondary cases were excluded.
bReverse-transcriptase real-time polymerase chain reaction (RT-PCR) assay cycle-threshold (Ct) values are inversely related to viral load (i.e. lower Ct values are associated
with higher viral load).
cOne index case had an influenza A (pH1N1) and influenza B coinfection. Household contacts exposed to this index case are included in both the influenza A (pH1N1)
and influenza B secondary infection risk estimates.
doi:10.1371/journal.pone.0075339.t003
Table 4. The serial interval for cases of household influenza transmission overall and by influenza type and subtype: the
Household Influenza Vaccine Effectiveness (HIVE) study, Ann Arbor Michigan, 2010-2011 influenza season.
Number of Secondary Influenza Casesa Mean Serial Intervalb 95% CIc
Any Influenza 30 3.2 2.4 – 3.9
A (H3N2) 17 2.5 1.8 – 3.3
A (pH1N1) 5 2.8 1.3 – 5.0
B 8 4.9 3.3 – 6.3
aAll 30 secondary influenza cases from resulting from all household introductions of influenza were included here.
bMean serial interval: mean days between onset of illness symptoms in index cases to onset of symptoms in transmission linked secondary cases.
c95% confidence intervals (95% CI) were calculated using bootstrap techniques with 1000 resamples.
doi:10.1371/journal.pone.0075339.t004
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27. Boëlle PY, Ansart S, Cori A, Valleron AJ (2011) Transmission parameters of the
A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respi
Viruses 5: 306–16.
28. Ng S, Cowling BJ, Fang VJ, Kwok HC, Ip DKM, et al. (2010) Effects of
oseltamivir treatment on duration of clinical illness and viral shedding and
household transmission of influenza virus. Clin Infect Dis 50: 707–14.
29. Monto AS, Gravenstein S, Elliot M, Colopy M, Schweinle J. (2000) Clinical
signs and symptoms predicting influenza infection. Arch Intern Med 160: 3243–
7.
30. Ohmit SE, Monto AS. (2006) Symptomatic predictors of influenza virus
positivity in children during the influenza season. Clin Infect Dis 43: 564–8.
31. Howard PF, McCaw JM, Richmond PC, Nissen M, Sloots T, et al. (2013) Virus
detection and its association with symptoms during influenza-like illness in a
sample of healthy adults enrolled in a randomized controlled vaccine trial.
Influenza Other Resp Viruses 7: 330–9.
32. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, et al.
(2012) A sentinel platform to evaluate influenza vaccine effectiveness and new
variant circulation, Canada 2010-2011 Season. Clin Infect Dis 55: 332–42.
Influenza Transmission in Households
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e75339
